JESSICA DIEKHOFF: Open Payments
NPI 1164662276 · ST. LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 32 payments from 12 companies in 2025. Trend: 2023 $857 · 2024 $1,101 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $317 |
| Novo Nordisk Inc | 2 | $32 |
| PFIZER INC. | 2 | $29 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Lilly USA, LLC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| Tris Pharma Inc | 1 | $16 |
| SANOFI PASTEUR INC. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: UBRELVY, VRAYLAR, QULIPTA, SHINGRIX, MOUNJARO, LEQVIO, FREESTYLE LIBRE 3, Wegovy.
Industry payments across MO — which companies pay providers there.
